You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 140 No. 8, August 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (5)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Dermatologic Disorders, Other
 •Drug Therapy
 •Adverse Effects
 •Alert me on articles by topic

VIGNETTES
Alcohol-Induced Application Site Erythema After Topical Immunomodulator Use and Its Inhibition by Aspirin

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The topical immunomodulators tacrolimus and pimecrolimus have proven effective in managing atopic dermatitis.1-2 Reported adverse effects are infrequent and most often consist of transient burning, warmth, or erythema at the application site upon initial use.1-2 We recently identified 3 patients who experienced application site erythema following the consumption of alcohol after using topical tacrolimus or pimecrolimus for the treatment of facial dermatoses. While this reaction has sometimes been mentioned for topical tacrolimus,3 there are no reports in the literature of this effect occurring with topical pimecrolimus. To study potential ways of alleviating this unwanted response, we conducted a double-blind controlled evaluation of 2 of the 3 patients after blocking 2 important mediators of vasodilatation, histamine and prostaglandins.

Methods

On days 1 through 12, participants applied 4 randomly coded preparations (0.1% tacrolimus ointment, 1.0% pimecrolimus cream, a control ointment, and a control cream) twice daily to 4 designated locations on the face . . . [Full Text of this Article]


Results

Comment
Benjamin D. Ehst, MD, PhD; Erin M. Warshaw, MD

Correspondence: Dr Warshaw, Department 111K Dermatology, Veterans Affairs Medical Center, Veterans Dr, Minneapolis, MN 55417 (erin.warshaw@med.va.gov).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Alcohol ingestion and topical tacrolimus: a disulfiram-like interaction?
Morales-Molina et al.
The Annals of Pharmacotherapy 2005;39:772-773.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.